Apollo Hospitals Enterprise Ltd.

Apollo Hospitals is currently trading at Rs. 625.90, up by 24.35 points or 4.05% from its previous closing of Rs. 601.55 on the BSE.

The scrip opened at Rs. 600.00 and has touched a high and low of Rs. 633.00 and Rs. 592.00 respectively. So far 22526 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 633.00 on 25-Nov-2011 and a 52 week low of Rs. 432.30 on 24-Jun-2011.

Last one week high and low of the scrip stood at Rs. 633.00 and Rs. 531.00 respectively. The current market cap of the company is Rs. 7903.01 crore.

The promoters holding in the company stood at 31.53% while Institutions and Non-Institutions held 38.03% and 28.92% respectively. 

Apollo Hospitals Enterprise is aiming to operate 100 ‘Sugar Clinics’ nationwide in the next three months. With physical infrastructure already there, the company will invest around Rs 30 crore on some specialised equipment for the clinics. At present, the company has 13 fully functional facilities having sugar clinics and will have 100 of them up and running in the next 90 days.

These clinics will manage the life cycle of a diabetic and work towards minimizing the associated humanity and morbidity and will on a specifically developed clinical pathway offering standardized care to the diabetic patients.

The prevalence of diabetes in India has reached the point of 3.7 percent of the total population. According to industry estimates India spends almost $21 billion on managing diabetes. Keeping in mind the rising burden of diabetes, India would need an integrated framework that would enable diabetics manage their lifestyle better. This would ensure reduction and prevention of complications, which is a key for these patients.